Biosergen AB (OSTO:BIOSGN) Marketable Securities: kr0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:BIOSGN Biosergen AB OSTO:BIOSGN
24 GF Score
Price kr0.55
View Full Analysis

What is Biosergen AB Marketable Securities?

Biosergen AB OSTO:BIOSGN -54.58% 24 Marketable Securities is kr0.00 Mil as of Dec. 2025. GuruFocus rates OSTO:BIOSGN with a GF Score™ of 24/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Biosergen AB's Marketable Securities for the quarter that ended in Dec. 2025 was kr0.00 Mil.

Biosergen AB  (OSTO:BIOSGN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Biosergen AB Marketable Securities Related Terms

Biosergen AB Marketable Securities Historical Data

* Premium members only.

The historical data trend for Biosergen AB's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosergen AB Marketable Securities Chart

Biosergen AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Biosergen AB Quarterly Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:BIOSGN
24GF Score
Biosergen AB OSTO:BIOSGN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biosergen AB Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of kr0.00 Mil mean?
Biosergen AB (OSTO:BIOSGN) has a Marketable Securities of kr0.00 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Biosergen AB and its competitors.
Is Biosergen AB's Marketable Securities too high?
Biosergen AB's current Marketable Securities is kr0.00 Mil. Overall, Biosergen AB has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Biosergen AB's Marketable Securities compare to VRTX and REGN?
Biosergen AB's Marketable Securities of kr0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Biosergen AB and its competitors. Biosergen AB's current Marketable Securities is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosergen AB stock overvalued right now?
Biosergen AB (OSTO:BIOSGN) has a current Marketable Securities of kr0.00 Mil. The current Marketable Securities is kr0.00 Mil. Biosergen AB's overall GF Score™ is 24/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Biosergen AB (OSTO:BIOSGN), the current Marketable Securities is kr0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosergen AB Business Description

Address Fogdevreten 2, Solna, SWE, 17165
Biosergen AB is a clinical stage biotechnology company advancing the treatment of life-threatening fungal infections. Biosergen' s mission is to develop the drug candidate BSG005 into a superior antifungal therapy with broader efficacy and improved safety over existing treatments. BSG005 potential is to eliminate fungal infections rather than just slowing their growth, reducing the risk of resistance.
24GF Score

Get the complete analysis for OSTO:BIOSGN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.55
Price